德意志銀行在諾和諾德股價較峰值下跌70%後，將這家Ozempic生產商的評級下調至賣出。此次下調評級打破了華爾街分析師此前不願建議投資者賣出諾和諾德股票的慣例。引述“華爾街分析師仍不願建議投資者賣出該股”— MarketWatch來源Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peakMarketWatch